List of Tables
Table 1. Global Nanoparticles Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031
Table 2. Key Players of Liposomes
Table 3. Key Players of Polymer-Conjugated Drugs
Table 4. Key Players of Polymeric Nanoparticles
Table 5. Key Players of Dendrimers
Table 6. Key Players of Inorganic Nanoparticles
Table 7. Key Players of Others
Table 8. Global Nanoparticles Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
Table 9. Global Nanoparticles Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Table 10. Global Nanoparticles Market Size by Region (2020-2025) & (US$ Million)
Table 11. Global Nanoparticles Market Share by Region (2020-2025)
Table 12. Global Nanoparticles Forecasted Market Size by Region (2026-2031) & (US$ Million)
Table 13. Global Nanoparticles Market Share by Region (2026-2031)
Table 14. Nanoparticles Market Trends
Table 15. Nanoparticles Market Drivers
Table 16. Nanoparticles Market Challenges
Table 17. Nanoparticles Market Restraints
Table 18. Global Nanoparticles Revenue by Players (2020-2025) & (US$ Million)
Table 19. Global Nanoparticles Market Share by Players (2020-2025)
Table 20. Global Top Nanoparticles Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Nanoparticles as of 2024)
Table 21. Ranking of Global Top Nanoparticles Companies by Revenue (US$ Million) in 2024
Table 22. Global 5 Largest Players Market Share by Nanoparticles Revenue (CR5 and HHI) & (2020-2025)
Table 23. Global Key Players of Nanoparticles, Headquarters and Area Served
Table 24. Global Key Players of Nanoparticles, Product and Application
Table 25. Global Key Players of Nanoparticles, Date of Enter into This Industry
Table 26. Mergers & Acquisitions, Expansion Plans
Table 27. Global Nanoparticles Market Size by Type (2020-2025) & (US$ Million)
Table 28. Global Nanoparticles Revenue Market Share by Type (2020-2025)
Table 29. Global Nanoparticles Forecasted Market Size by Type (2026-2031) & (US$ Million)
Table 30. Global Nanoparticles Revenue Market Share by Type (2026-2031)
Table 31. Global Nanoparticles Market Size by Application (2020-2025) & (US$ Million)
Table 32. Global Nanoparticles Revenue Market Share by Application (2020-2025)
Table 33. Global Nanoparticles Forecasted Market Size by Application (2026-2031) & (US$ Million)
Table 34. Global Nanoparticles Revenue Market Share by Application (2026-2031)
Table 35. North America Nanoparticles Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 36. North America Nanoparticles Market Size by Country (2020-2025) & (US$ Million)
Table 37. North America Nanoparticles Market Size by Country (2026-2031) & (US$ Million)
Table 38. Europe Nanoparticles Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 39. Europe Nanoparticles Market Size by Country (2020-2025) & (US$ Million)
Table 40. Europe Nanoparticles Market Size by Country (2026-2031) & (US$ Million)
Table 41. Asia-Pacific Nanoparticles Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031
Table 42. Asia-Pacific Nanoparticles Market Size by Region (2020-2025) & (US$ Million)
Table 43. Asia-Pacific Nanoparticles Market Size by Region (2026-2031) & (US$ Million)
Table 44. Latin America Nanoparticles Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 45. Latin America Nanoparticles Market Size by Country (2020-2025) & (US$ Million)
Table 46. Latin America Nanoparticles Market Size by Country (2026-2031) & (US$ Million)
Table 47. Middle East & Africa Nanoparticles Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 48. Middle East & Africa Nanoparticles Market Size by Country (2020-2025) & (US$ Million)
Table 49. Middle East & Africa Nanoparticles Market Size by Country (2026-2031) & (US$ Million)
Table 50. Novartis Company Details
Table 51. Novartis Business Overview
Table 52. Novartis Nanoparticles Product
Table 53. Novartis Revenue in Nanoparticles Business (2020-2025) & (US$ Million)
Table 54. Novartis Recent Development
Table 55. Gilead Sciences Company Details
Table 56. Gilead Sciences Business Overview
Table 57. Gilead Sciences Nanoparticles Product
Table 58. Gilead Sciences Revenue in Nanoparticles Business (2020-2025) & (US$ Million)
Table 59. Gilead Sciences Recent Development
Table 60. Johnson & Johnson Company Details
Table 61. Johnson & Johnson Business Overview
Table 62. Johnson & Johnson Nanoparticles Product
Table 63. Johnson & Johnson Revenue in Nanoparticles Business (2020-2025) & (US$ Million)
Table 64. Johnson & Johnson Recent Development
Table 65. Amgen Company Details
Table 66. Amgen Business Overview
Table 67. Amgen Nanoparticles Product
Table 68. Amgen Revenue in Nanoparticles Business (2020-2025) & (US$ Million)
Table 69. Amgen Recent Development
Table 70. Sigma-Tau Pharmaceuticals Company Details
Table 71. Sigma-Tau Pharmaceuticals Business Overview
Table 72. Sigma-Tau Pharmaceuticals Nanoparticles Product
Table 73. Sigma-Tau Pharmaceuticals Revenue in Nanoparticles Business (2020-2025) & (US$ Million)
Table 74. Sigma-Tau Pharmaceuticals Recent Development
Table 75. Abraxis Biosciences Company Details
Table 76. Abraxis Biosciences Business Overview
Table 77. Abraxis Biosciences Nanoparticles Product
Table 78. Abraxis Biosciences Revenue in Nanoparticles Business (2020-2025) & (US$ Million)
Table 79. Abraxis Biosciences Recent Development
Table 80. Nano Interface Technology Company Details
Table 81. Nano Interface Technology Business Overview
Table 82. Nano Interface Technology Nanoparticles Product
Table 83. Nano Interface Technology Revenue in Nanoparticles Business (2020-2025) & (US$ Million)
Table 84. Nano Interface Technology Recent Development
Table 85. Research Programs/Design for This Report
Table 86. Key Data Information from Secondary Sources
Table 87. Key Data Information from Primary Sources
Table 88. Authors List of This Report
List of Figures
Figure 1. Nanoparticles Picture
Figure 2. Global Nanoparticles Market Size Comparison by Type (2020-2031) & (US$ Million)
Figure 3. Global Nanoparticles Market Share by Type: 2024 VS 2031
Figure 4. Liposomes Features
Figure 5. Polymer-Conjugated Drugs Features
Figure 6. Polymeric Nanoparticles Features
Figure 7. Dendrimers Features
Figure 8. Inorganic Nanoparticles Features
Figure 9. Others Features
Figure 10. Global Nanoparticles Market Size by Application (2020-2031) & (US$ Million)
Figure 11. Global Nanoparticles Market Share by Application: 2024 VS 2031
Figure 12. Hospitals Case Studies
Figure 13. Ambulatory Surgery Centers Case Studies
Figure 14. Diagnostic Centers Case Studies
Figure 15. Nanoparticles Report Years Considered
Figure 16. Global Nanoparticles Market Size (US$ Million), Year-over-Year: 2020-2031
Figure 17. Global Nanoparticles Market Size, (US$ Million), 2020 VS 2024 VS 2031
Figure 18. Global Nanoparticles Market Share by Region: 2024 VS 2031
Figure 19. Global Nanoparticles Market Share by Players in 2024
Figure 20. Global Top Nanoparticles Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Nanoparticles as of 2024)
Figure 21. The Top 10 and 5 Players Market Share by Nanoparticles Revenue in 2024
Figure 22. North America Nanoparticles Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 23. North America Nanoparticles Market Share by Country (2020-2031)
Figure 24. United States Nanoparticles Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 25. Canada Nanoparticles Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 26. Europe Nanoparticles Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 27. Europe Nanoparticles Market Share by Country (2020-2031)
Figure 28. Germany Nanoparticles Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 29. France Nanoparticles Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 30. U.K. Nanoparticles Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 31. Italy Nanoparticles Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 32. Russia Nanoparticles Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 33. Nordic Countries Nanoparticles Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 34. Asia-Pacific Nanoparticles Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 35. Asia-Pacific Nanoparticles Market Share by Region (2020-2031)
Figure 36. China Nanoparticles Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 37. Japan Nanoparticles Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 38. South Korea Nanoparticles Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 39. Southeast Asia Nanoparticles Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 40. India Nanoparticles Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 41. Australia Nanoparticles Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 42. Latin America Nanoparticles Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 43. Latin America Nanoparticles Market Share by Country (2020-2031)
Figure 44. Mexico Nanoparticles Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 45. Brazil Nanoparticles Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 46. Middle East & Africa Nanoparticles Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 47. Middle East & Africa Nanoparticles Market Share by Country (2020-2031)
Figure 48. Turkey Nanoparticles Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 49. Saudi Arabia Nanoparticles Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 50. UAE Nanoparticles Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 51. Novartis Revenue Growth Rate in Nanoparticles Business (2020-2025)
Figure 52. Gilead Sciences Revenue Growth Rate in Nanoparticles Business (2020-2025)
Figure 53. Johnson & Johnson Revenue Growth Rate in Nanoparticles Business (2020-2025)
Figure 54. Amgen Revenue Growth Rate in Nanoparticles Business (2020-2025)
Figure 55. Sigma-Tau Pharmaceuticals Revenue Growth Rate in Nanoparticles Business (2020-2025)
Figure 56. Abraxis Biosciences Revenue Growth Rate in Nanoparticles Business (2020-2025)
Figure 57. Nano Interface Technology Revenue Growth Rate in Nanoparticles Business (2020-2025)
Figure 58. Bottom-up and Top-down Approaches for This Report
Figure 59. Data Triangulation
Figure 60. Key Executives Interviewed